Search results
Abbott (ABT) Gets FDA Nod for Two Glucose Monitoring Systems
Zacks via Yahoo Finance· 3 days agoAbbott ABT announced that Lingo and Libre Rio, two of its glucose monitoring system, have received...
Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring...
Morningstar· 6 days agoAbbott's consumer biowearable, Lingo™, is designed for general consumers who are looking to improve their overall health and wellnessLibre Rio™ is designed for adults with Type 2 diabetes who ...
Abbott secures FDA clearance for two over-the-counter glucose monitors
Reuters via Yahoo News· 5 days agoThe devices, one for the health-conscious and another for those with diabetes, follow the company's ...
FDA clears Abbott's two new glucose monitors By Investing.com
Investing.com· 5 days agoAbbott has received U.S. Food and Drug Administration (FDA) clearance for its two latest...
Biowearables 101: Health Tech That Goes Deeper
Morningstar· 3 days agoThe insights come from the biowearable's sensor, which measures your glucose level and relays that data every minute. The rise of biowearables started in the medical space ...
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
Investor's Business Daily· 5 days agoBut experts say CGMs will also play a big part in monitoring glucose for people taking GLP-1 drugs...
Abbott claims FDA clearances for pair of over-the-counter diabetes trackers
FierceBiotech· 5 days agoThe company has collected FDA clearances for two separate continuous glucose monitoring systems, the...
Olympic athletes use diabetes glucose monitors to hone performance, training
Fox News· 6 days agoContinuous glucose monitors (CGMs) are coin-sized adhesive skin patches with a Bluetooth link to a...
Microneedle Glucose Sensors Keep Monitoring Skin-Deep
IEEE Spectrum· 5 days agoFor people with diabetes, glucose monitors are a valuable tool to monitor their blood sugar. The...
2 Healthcare Stocks to Buy Hand Over Fist in June
Motley Fool via Yahoo Finance· 4 days agoStill, medical devices remain the company's main driver, from its heart failure products to its diabetes care business. That includes Abbott's continuous...
